WhatsApp:13723756974
Deoxynucleotide Triphosphates,Sodium Salt (dNTPs)
For sale: dATP, dCTP, dGTP, dTTP, dUTP, dNTP
Description
High-quality deoxynucleotide triphosphates (dNTPs) are critical for the success of many key procedures such as PCR, cDNA synthesis, sequencing and labeling. Our dNTPs are provided at a concentration of 10mM in aqueous solution at pH 7.0±0.1 and have the HPLC purity of greater than 99%.
Features
Dependable: Tested with kinds of DNA polymerase, ensuring optimal performance.
Consistent: dNTPs are >99% pure, allowing highly consistent results.
Convenient: Supplied at a convenient concentration (10mM in water) for ease-of-use in PCR and other applications.
Storage Conditions
Store at –20°C. Avoid exposure to frequent temperature changes.
Please contact us for more information.
bio-equip.cn
You can add our WhatsApp number.
WhatsApp:13723756974
Company Profile
Founded in 2017, our company is dedicated to the development of pulmonary drug delivery systems for small animals. Our core product, the small animal pulmonary drug delivery device, has been refined over nearly a decade of development. To date, more than 30 research papers with a cumulative impact factor of 400+ have been published using our products.
Bojian Biotechnology Co., Ltd. specializes in the development, manufacturing, and sales of consumables, instruments, and related products for structural biology.
Our current business focuses on providing consumables, reagents, and instruments for protein crystal growth, including:
Consumables:
Sitting-drop plates, hanging-drop plates (pre-greased / pre-coated with sealant), siliconeized cover slides, sealing films, hanging-drop films, loops with bases, LCP (lipidic cubic phase) consumables, crystallization screening kits, and more.
Tools:
Puck tool kits, CX100 liquid nitrogen dewar, CX100 cryo-shipping container (dry shipping dewar), foam dewars, cryo-handling tools, and more.
Instruments:
Protein crystallization dispensing workstation, screening kit dispensing workstation, protein crystallization incubator, crystal observation microscope, and more.
PPaper FOR PenWu Device 论文期刊
Paper FOR PenWu Device
After the customers used our products, the total impact factor of the papers they published reached over 500.
You can search in these papers: BJ-PW-M & BJ-PW-R & BJ-PW-FM-M & BJ-PW-FM-R & Bio Jane & PenWu Device for Mouse & PenWu Device for Rat and so on. These papers will show that.
Note: The impact factor (IF) is based on the latest version of JCR (2025 annual IF, released in June 2026); those marked (2024) refer to the 2024 IF (released in June 2025); the symbol "≈" indicates an approximate value; duplicate entries have been noted. Each paper is accompanied by a link to the original text (Link).
Liquid(液体剂型,共 36 条)
1. Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis — Advanced Materials — IF = 29.1
- Link: https://onlinelibrary.wiley.com/doi/abs/10.1002/adma.202007557
2. Inhalable nanocatchers for SARS-CoV-2 inhibition — PNAS — IF = 11.1
- Link: https://www.pnas.org/doi/full/10.1073/pnas.2102957118
3. Renal-Clearable Molecular Probe for Near-Infrared Fluorescence Imaging and Urinalysis of SARS-CoV-2 — Journal of the American Chemical Society (JACS) — IF = 15.0
- Link: https://pubs.acs.org/doi/10.1021/jacs.1c08017
4. Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis — Acta Pharmacologica Sinica — IF = 6.9
- Link: https://www.nature.com/articles/s41401-021-00808-z
5. Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells — Acta Pharmacologica Sinica — IF = 6.9
- Link: https://www.nature.com/articles/s41401-021-00618-3
6. ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment — Acta Biomaterialia — IF = 10.4
- Link: https://www.sciencedirect.com/science/article/pii/S1742706122003634
7. A chitosan-mediated inhalable nanovaccine against SARS-CoV-2 — Nano Research — IF = 9.5 (2024)
- Link: https://doi.org/10.1007/s12274-021-4012-9
8. p55PIK deficiency and its NH2-terminal derivative inhibit inflammation and emphysema in COPD mouse model — American Journal of Physiology-Lung Cellular and Molecular Physiology — IF = 3.8
- Link: https://journals.physiology.org/doi/full/10.1152/ajplung.00560.2020
9. Macrophage-targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis — Bioengineering & Translational Medicine — IF = 6.2
- Link: https://doi.org/10.1002/btm2.10280
10. The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation — European Respiratory Journal — IF = 23.8
- Link: https://doi.org/10.1183/13993003.03697-2020
11. MTMR14 Alleviates Chronic Obstructive Pulmonary Disease as a Regulator in Inflammation and Emphysema — Oxidative Medicine and Cellular Longevity — IF ≈ 4.6
- Link: https://www.hindawi.com/journals/omcl/2022/9300269/
12. A cytoderm metabolic labeling AIEgen for rapid detection and intracellular ablation of Mycobacterium tuberculosis — Journal of Innovative Optical Health Sciences — IF ≈ 2.6
- Link: https://www.sciencedirect.com/science/article/pii/S2666386422005641
13. A Multifunctional Nanoparticle Mitigating Cytokine Storm by Scavenging Multiple Inflammatory Mediators of Sepsis — ACS Nano — IF = 17.3
- Link: https://pubs.acs.org/doi/full/10.1021/acsnano.3c00906
14. Inhaled Lipid Nanoparticles Alleviate Established Pulmonary Fibrosis — Small — IF = 12.1 (2024)
- Link: https://onlinelibrary.wiley.com/doi/10.1002/smll.202300545
15. Local administration of liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis by modulating macrophage polarization — Science China Life Sciences — IF = 9.6
- Link: https://www.sciengine.com/SCLS/doi/10.1007/s11427-022-2314-8
16. Inhalable pH-responsive DNA tetrahedron nanoplatform for boosting anti-tumor immune responses against metastatic lung cancer — Biomaterials — IF ≈ 12.9 (2024)
- Link: https://doi.org/10.1016/j.biomaterials.2023.122283
17. Inhalable Bottlebrush Polymer Bioconjugates as Vectors for Efficient Pulmonary Delivery of Oligonucleotides — ACS Nano — IF = 17.3
- Link: https://doi.org/10.1021/acsnano.3c08660
18. Systemic Protein Delivery via Inhalable Liposomes: Formulation and Pharmacokinetics — Pharmaceutics — IF = 5.4 (2024)
- Link: https://doi.org/10.3390/pharmaceutics15071951
19. Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice — Nature Communications — IF = 18.1
- Link: https://www.nature.com/articles/s41467-024-50312-1
20. Inhalation of Bioorthogonal Gene-Editable Spiky-Pollen Reprograms Tumor-Associated Macrophages for Lung Cancer Immunotherapy — Advanced Functional Materials — IF = 19.9
- Link: https://doi.org/10.1002/adfm.202408767
21. ACE2 Receptor-Targeted Inhaled Nanoemulsions Inhibit SARS-CoV-2 and Attenuate Inflammatory Responses — Advanced Materials — IF = 29.1
- Link: https://doi.org/10.1002/adma.202311537
22. Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis — Journal of Translational Medicine — IF = 9.7
- Link: https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05655-0
23. Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis — ACS Nano — IF = 17.3
- Link: https://pubs.acs.org/doi/10.1021/acsnano.4c15130
24. Corrugated surface microparticles with chitosan and levofloxacin for improved aerodynamic performance — Journal of Drug Delivery Science and Technology — IF = 5.2
- Link: https://www.sciencedirect.com/science/article/pii/S1818087623000429
25. Chemically Programmed Hydrogels for Spatiotemporal Modulation of the Cardiac Pathological Microenvironment — Advanced Materials — IF = 29.1
- Link: https://doi.org/10.1002/adma.202404264
26. Construct nucleic acid delivery carriers with excellent antibacterial capabilities for the treatment of bacterial MRSA-induced lung inflammation — Science China Chemistry — IF = 10.4 (2024)
- Link: https://doi.org/10.1007/s11426-024-2600-1
27. Kynurenine acts as a signaling molecule to attenuate pulmonary fibrosis by enhancing the AHR-PTEN axis — Life Sciences — IF = 6.1 (2024)
- Link: https://www.sciencedirect.com/science/article/pii/S2090123224002546
28. Harnessing Surface Hydrophilicity of Inhalable Nanoparticles for Precision Delivery of Glucagon-like Peptide-1 Receptor Agonists or Anti-Asthmatic Therapeutics — ACS Nano — IF = 17.3
- Link: https://doi.org/10.1021/acsnano.5c05745
29. Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage — Nature Communications — IF = 18.1
- Link: https://www.nature.com/articles/s41467-023-40185-1
30. Inhalable Respiratory Driven Penetration of Porous Microsphere-Based Mucosal Vaccine for Long-Term Immune Protection — Advanced Materials — IF = 29.1
- Link: https://doi.org/10.1002/adma.72696
31. A ferret model demonstrates sustained fibrosis, restrictive physiology, and airway proximalization — npj Regenerative Medicine — IF = 7.0
- Link: https://www.nature.com/articles/s41536-025-00436-9
32. Inhalational therapy of pulmonary infection via macrophage-targeted nanoemulsion — Acta Pharmaceutica Sinica B — IF = 14.6
- Link: https://doi.org/10.1016/j.apsb.2026.02.026
33. Disease landscape–guided design of neutrophil-specific reporters for early and accurate pneumonia detection in vivo and in urine — Science Advances — IF = 13.9
- Link: https://www.science.org/doi/10.1126/sciadv.aeb4417
34. An enhanced mucus-penetrating miRNA delivery system for effective inhibition of bleomycin-induced pulmonary fibrosis in mice — Cell Biomaterials — 新刊,暂无 IF
- Link: https://www.cell.com/cell-biomaterials/fulltext/S3050-5623(25)00293-400293-4)
Liquid 小计(34 篇论文,IF 合计约 449)
Dry powder(干粉剂型,共 6 条)
1. Co-achievement of enhanced absorption and elongated retention of insoluble drug in lungs for inhalation therapy of pulmonary fibrosis — Powder Technology — IF = 4.9 (2024)
- Link: https://doi.org/10.1016/j.powtec.2022.117679
2. Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation — Journal of Controlled Release — IF = 12.4
- Link: https://www.sciencedirect.com/science/article/pii/S0168365923002791
3. Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration — Pharmaceutics 2022, 14, 2819 — IF = 5.4 (2024)
- Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786194/
4. Corrugated surface microparticles with chitosan and levofloxacin… — Journal of Drug Delivery Science and Technology — 与 Liquid 第 26 条相同 — (IF = 5.2)
- Link: https://www.sciencedirect.com/science/article/pii/S1818087623000429
5. An inhalable composite particulate system for targeted delivery of therapeutics deep into small airways: in vitro and in vivo evaluation — International Journal of Pharmaceutics — IF = 5.8 (2024)
- Link: https://www.sciencedirect.com/science/article/abs/pii/S0378517325008907
6. Inhalable Respiratory Driven Penetration of Porous Microsphere-Based Mucosal Vaccine… — Advanced Materials — 与 Liquid 第 32 条相同 — (IF = 29.1)
- Link: https://doi.org/10.1002/adma.72696
Dry powder 6 high-quality papers, with an IF total of approximately 62.8)
Summary
- A total of 40 papers, covering 24 different journals, have a combined IF of approximately 511.8 (calculated based on the IF of each paper's respective journal).
- Total impact factor of the client's published papers exceeds 500 ✓
- The highest IF: Advanced Materials 29.1 (6 papers), ERJ 23.8, AFM 19.9, Nature Communications 18.1 (2 papers), ACS Nano 17.3 (4 papers)
- There are a total of 12 journals with an IF of ≥ 10, covering 20 papers
- The original links (Link) for each paper are provided, and they can be directly clicked to access.
韩国 College of Pharmacy Chungbuk National University 忠北国立大学药学院
美国University of Illinois at Chicago / College of Medicine 伊利诺伊大学芝加哥分校/医学院
美国 Johns Hopkins University 约翰霍普金斯大学
德国 吉森大学Justus-Liebig-Universität Gießen
美国 Moores Cancer Center 穆尔斯癌症中心
美国 The University of Texas at El Paso - UTEP 德克萨斯大学埃尔帕索-乌特普分校
法国 University of Tours 图尔大学
瑞典 Truly Labs
美国 Earli, Inc.
美国 University of Mississippi School of Pharmacy 密西西比大学药学院
俄罗斯 National Research Center for Epidemiology and Microbiology 国家流行病学和微生物学研究中心
比利时 InhaTarget Therapeutics (ULB)
美国 UNC School of Medicine 北卡罗来纳大学医学院
台湾 紘 程 科 技 有 限 公 司
美国 University of Pittsburgh 匹兹堡大学
奥地利 AIT Austrian Institute of Technology GmbH 奥地利技术研究院有限公司(Two)
德国 Charité – Universit tsmedizin Berlin 柏林夏里特医学院
丹麦 Aarhus University 奥尔胡斯大学
法国 University of Tours 图尔大学
法国 Université de Bordeaux 波尔多大学
美国 Northeastern University 东北大学
美国 San Diego State University 圣地亚哥州立大学
意大利 University of Padova 帕多瓦大学
韩国 Inbon medical
乌克兰 ENAMINE UA Ltd
美国 Cen-Med Enterprises(17 sets )
法国 BIONEA LAB(Two)
美国 Massachusetts General Hospital 马萨诸塞州综合医院
韩国 Pohang University of Science and Technology 浦项科技大学
澳大利亚 The Woolcock Institute of Medical Research, University of Sydney 悉尼大学伍尔考克医学研究所
美国 Edenbridge Pharmaceuticals, LLC
日本 BoZo Research Center Inc.(3套)
美国 Dicerna Pharmaceuticals, Inc.
以色列 Aposense
新加坡 Singapore General Hospital Research Laboratory 新加坡总医院研究实验室
加拿大 Genevant Sci Corp.
波兰 Prospecta Sp. z o.o.
广州医科大学 Guangzhou Medical University (Two sets)
浙江海正药业股份有限公司 Zhengjiang Hissun Pharmaceutical CO.,LTD
中国科学院上海药物研究所Chinese Academy of Sciences Shanghai Institute of Materia Medica (Eight sets )
韩国 圆光大学 Wonkwang University(Three sets )
不列颠哥伦比亚大学 The University of British Columbia
纽约西奈山医学院 Mount Sinai School of Medicine(Two sets)
海思科药业集团股份有限公司 Haisco Pharmaceutical Group
中山大学肿瘤医院 Sun Yat-sen University Cancer Center
克瑞顿大学 Creighton University
温州医科大学附属第一医院 The First Affiliated Hospital of Wenzhou Medical University(Three sets )
迪哲医药(阿斯利康)Dizal Pharma(AstraZeneca)(Eight sets)
陆军军医大学 XXXXX Medical University
慕尼黑理工大学 Institute of Pharmacology and Toxicology, Technical University Munich
天津市医药科学研究所 Tianjin institute of medical sciences (Two sets)
塔夫斯大学医学院 Tufts University School of Medicine
华中科技大学附属同济医院 Tongji Medical College of HUST (Five sets)
韩国 延世大学 Yonsei university (Four sets)
康龙化成(北京)新药技术有限公司 Pharmaron Beijing Co., Ltd (Three sets )
奥塔哥大学 University of Otago(Two sets)
苏州大学 Soochow University(Three sets )
天津市中医医学工程研究所 Tianjin institute of medical engineering of traditional Chinese medicine
中国科学院长春应用化学研究所 Changchun Institute of Applied Chemistry
中国科学院武汉病毒研究所 Wuhan Institute of Virology ,CAS
意大利药企 Recordati S.P.A. (Two sets)
中国人民解放军军事医学科学院 Academy of Military Medical Sciences
首都儿科研究所 Capital Institute of Pediatrics
西班牙CIC biomaGUNE研究中心 CIC biomaGUNE
北卡罗来纳大学教堂山分校 University of North Carolina at Chapel Hill (Three sets )
爱荷华大学 University of Iowa
山东大学 Shandong University
阿拉巴马大学伯明翰分校 University of Alabama at Birmingahm(Four sets)
意大利 佩鲁贾大学 Università degli Studi di Perugia
国立釜山大学 Pusan National University
忠北大学 Chungbuk National University
蒙纳士大学 Monash University
佛罗伦萨大学 University of Florence
加拿大生物制药公司 Prometic Biosciences Inc. (Three sets )
隆德大学 Lund University
中国人民解放军xxxxx医学中心(Two sets )
中科院自动化研究所 Institute of Automation,Chinese Academy of Sciences
锦州医科大学 Jinzhou Medical University
加拿大 IPS Therapeutique
韩国忠北大学 Chungbuk National University
伊利诺伊大学芝加哥分校 University of Illinois at Chicago
苏州普瑞康生物医药有限公司(Three sets )
陆军军医大学 XXXXX Medical University (无偿捐赠一套,用于研究2019新型冠状病毒(SARS-CoV-2)疫苗)
比利时 鲁汶大学KU Leuven
霍普金斯大学医学院 Johns Hopkins University School of Medicine
德国 吉森大学Justus-Liebig-Universität Gießen (Three sets )
加拿大 IPS Therapeutique, Inc. (Two)
韩国 NADIANBIO Research Facility(Two)
加利福尼亚大学圣迭戈分校 University of California, San Diego
德克萨斯大学埃尔帕索分校 The University of Texas at El Paso
希腊Bioemtech
清华大学 Tsinghua University
南方医科大学 Southern Medical University 用于SARS-CoV-2新型冠状病毒研究
药明康德 WuXi Apptec(Three sets )
中国科学院合肥物质科学研究院(Hefei Institute of Physical Science,Chinese Academy of Sciences)
山东绿叶制药
曙光医院
华东理工大学
中国医学科学院药用植物研究所
浙一医院
中山大学药学院
天津大学海河医院